GGN
Basic information
Region (hg38): 19:38384266-38388082
Links
Phenotypes
GenCC
Source:
- spermatogenic failure 69 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spermatogenic failure 69 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary | 31985809; 33108537 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GGN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 36 | 47 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 10 | 8 |
Variants in GGN
This is a list of pathogenic ClinVar variants found in the GGN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-38384432-G-A | GGN-related disorder | Benign/Likely benign (Dec 01, 2023) | ||
19-38384432-G-C | Benign (Dec 31, 2019) | |||
19-38384525-T-C | not specified | Uncertain significance (Sep 26, 2023) | ||
19-38385436-C-T | not specified | Uncertain significance (May 31, 2023) | ||
19-38385449-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
19-38385557-C-A | not specified | Uncertain significance (Apr 26, 2024) | ||
19-38385619-G-A | not specified | Uncertain significance (May 16, 2024) | ||
19-38385622-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
19-38385623-C-T | Benign (Dec 31, 2019) | |||
19-38385650-T-C | not specified | Uncertain significance (Aug 16, 2022) | ||
19-38385692-G-T | not specified | Uncertain significance (Jan 10, 2023) | ||
19-38385740-A-G | not specified | Uncertain significance (Aug 10, 2023) | ||
19-38385765-A-AGCCGGGGATGGGGCCGGGGCCGGG | Benign (Dec 31, 2019) | |||
19-38385791-C-T | GGN-related disorder | Likely benign (May 31, 2023) | ||
19-38385820-G-T | not specified | Uncertain significance (Aug 04, 2021) | ||
19-38385847-T-C | not specified | Uncertain significance (Dec 06, 2021) | ||
19-38385863-G-C | not specified | Uncertain significance (Jan 25, 2024) | ||
19-38385910-G-A | not specified | Uncertain significance (May 08, 2023) | ||
19-38385916-AGTGTGGGCGGCG-A | Uncertain significance (Jan 01, 2024) | |||
19-38385975-C-T | not specified | Likely benign (Feb 17, 2024) | ||
19-38385990-GC-G | Spermatogenic failure 69 | Pathogenic (Apr 05, 2022) | ||
19-38386048-C-T | Benign (Dec 31, 2019) | |||
19-38386085-G-A | Benign/Likely benign (May 01, 2024) | |||
19-38386118-C-T | Benign (Dec 31, 2019) | |||
19-38386129-C-T | not specified | Uncertain significance (Mar 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GGN | protein_coding | protein_coding | ENST00000334928 | 2 | 3818 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00186 | 0.977 | 125686 | 0 | 40 | 125726 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.395 | 399 | 422 | 0.946 | 0.0000305 | 3912 |
Missense in Polyphen | 49 | 61.421 | 0.79777 | 523 | ||
Synonymous | 2.79 | 159 | 210 | 0.755 | 0.0000167 | 1581 |
Loss of Function | 2.03 | 7 | 15.7 | 0.447 | 9.17e-7 | 153 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000293 | 0.000270 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.000168 | 0.000163 |
Finnish | 0.000144 | 0.000139 |
European (Non-Finnish) | 0.000171 | 0.000149 |
Middle Eastern | 0.000168 | 0.000163 |
South Asian | 0.000236 | 0.000229 |
Other | 0.000194 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in spermatogenesis. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.114
Haploinsufficiency Scores
- pHI
- 0.0553
- hipred
- N
- hipred_score
- 0.254
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0208
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ggn
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- double-strand break repair;gamete generation;spermatogenesis;embryo implantation;protein localization;cell differentiation
- Cellular component
- nucleolus;perinuclear region of cytoplasm
- Molecular function
- protein binding;ubiquitin protein ligase binding;protein dimerization activity